News
Our latest moves
All
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Press
Gen Eng News
January 15, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy
Announcements
January 13, 2025
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Press
Technology Networks
November 27, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Roche Bets Up to $1 Billion to Solve Gene Therapy’s Big Problem
Press
Bloomberg
October 24, 2024
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Low-N OpenFold fine-tuning improves peptide design without additional structures
Publications
NeurIPS MLSB
October 4, 2024
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI-powered Gene Therapy Platform
Announcements
May 6, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Announcements
April 26, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Announcements
April 26, 2021
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Announcements
October 14, 2020
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Announcements
October 14, 2020
Xconomy names Dyno Therapeutics 2020 Startup of the Year
Announcements
September 24, 2020
Xconomy names Dyno Therapeutics 2020 Startup of the Year
Announcements
September 24, 2020
Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases
Announcements
May 11, 2020
Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases
Announcements
May 11, 2020
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy using Artificial Intelligence
Announcements
May 11, 2020
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy using Artificial Intelligence
Announcements
May 11, 2020
Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology
Announcements
May 11, 2020
Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology
Announcements
May 11, 2020
Dyno Therapeutics announces publication in Nature Biotechnology demonstrating use of artificial intelligence to generate unprecedented diversity of AAV capsids and broaden reach of gene therapies
Announcements
February 11, 2020
Dyno Therapeutics announces publication in Nature Biotechnology demonstrating use of artificial intelligence to generate unprecedented diversity of AAV capsids and broaden reach of gene therapies
Announcements
February 11, 2020
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthroughs in AI Methods for AAV Capsid Design at ASGCT Annual Meeting and SynBioBeta Global Synthetic Biology Conference
Events
April 23, 2024
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present on Breakthrough Optimized AAV Capsids for Eye and CNS Gene Delivery at ESGCT Annual Congress
Events
October 11, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Events
May 2, 2023
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics at Goldman Sachs Byte-ology Conference
Events
December 9, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
Events
May 11, 2021
Deep diversification of an AAV capsid protein by machine learning
Publications
Nature Biotechnology
February 11, 2021
Deep diversification of an AAV capsid protein by machine learning
Publications
Nature Biotechnology
February 11, 2021
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
AdaLead: A simple and robust adaptive greedy search algorithm for sequence design
Publications
Arxiv
October 5, 2020
A primer on model-guided exploration of fitness landscapes for biological sequence design
Publications
Arxiv
October 4, 2020
A primer on model-guided exploration of fitness landscapes for biological sequence design
Publications
Arxiv
October 4, 2020
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Publications
Science
November 29, 2019
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Publications
Science
November 29, 2019
Roche turns to a Harvard upstart out of George Church’s lab to construct AAV 2.0 model vectors — a key part of building the gene therapy pipeline
Press
Endpoints News
October 14, 2020
Roche turns to a Harvard upstart out of George Church’s lab to construct AAV 2.0 model vectors — a key part of building the gene therapy pipeline
Press
Endpoints News
October 14, 2020
Roche Enlists Dyno to Bring AI to NExt_Generation Liver, CNS Gene Therapies
Press
BioProcess International
October 14, 2020
Roche Enlists Dyno to Bring AI to NExt_Generation Liver, CNS Gene Therapies
Press
BioProcess International
October 14, 2020
The 2020 National Xconomy Awards Winner - Startup of the Year
Press
BioXconomy
September 4, 2020
The 2020 National Xconomy Awards Winner - Startup of the Year
Press
BioXconomy
September 4, 2020
Dyno advances AI-powered gene therapy
Press
Nature Biotechnology
June 9, 2020
Dyno advances AI-powered gene therapy
Press
Nature Biotechnology
June 9, 2020
Novartis and Sarepta tap Dyno Therapeutics to use machine learning for gene therapy
Press
Chemical and Engineering News
May 13, 2020
Novartis and Sarepta tap Dyno Therapeutics to use machine learning for gene therapy
Press
Chemical and Engineering News
May 13, 2020
Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier
Press
BioWorld
May 11, 2020
Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier
Press
BioWorld
May 11, 2020